×
To start your customized experience click the start button
Customize
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2017
CURE Communications Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Head and neck

Brielle Urciuoli
Nurses at the Cleveland Clinic are pushing to make survivorship care the norm for survivors of head and neck cancer.
Christian M. Capitini, M.D.
Melanoma should not be considered to be in a "special category" that responds well to immunotherapy, according to Christian M. Capitini, M.D., assistant professor of Pediatrics at the University of Wisconsin.
A panel of experts recently discussed the evolving field of immunotherapy for solid tumor types.
Silas Inman
The combination of lirilumab Opdivo proved to be effective for a subet of patients with head and neck cancer, according to a recent study.
Allie Strickler
Everett Vokes, M.D. discusses what the future of immunotherapy might mean for patients with head and neck cancer.
Jason M. Broderick
Opdivo was approved for patients with metastatic or recurrent squamous cell carcinoma of the head and neck. 
Laura Panjwani
In an interview with CURE, James Allison, Ph.D. talks about the progress immunotherapy has made, as well as potential combinations with immunotherapy and other treatment types to provide better outcomes for patients.
Staff Writer
The addition of immunotherapy did not show an improved progression-free survival for some patients with head and neck cancer.
Laura Panjwani
The approval of Keytruda for metastatic head and neck squamous cell carcinoma is just the beginning when it comes to treating head and neck cancer with immunotherapy.
Silas Inman
An accelerated FDA approval has been granted to the immunotherapy Keytruda for patients with recurrent or metastatic head and neck squamous cell carcinoma following progression on a platinum-containing chemotherapy.
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×

Sign Up

In Treatment

Maintenance/Hormone Treatment

Out of Treatment

Caregiver

Healthcare Professional

Not Applicable